miR-31 expression was found to be up-regulated in BRAF-mutated (V600E) CRC, compared to the wild-type BRAF carriers, indicating it to be an independent unfavourable prognostic factor, and to correlate with SSA/P and TSA, confirming its oncogenic role in the serrated pathway [209]. The gene discussed is BRAF; the disease is colorectal carcinoma.